Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,733 | 0 | 0 | N/A | 0 |
| Receivables | 58 | 0 | 0 | N/A | 0 |
| TOTAL | $18,347 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 3,021 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 700 | 0 | 0 | 0 | 0 |
| TOTAL | $3,721 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $22,068 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 2,530 | 0 | 0 | N/A | 0 |
| TOTAL | $7,275 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,434 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,202 | 0 | 0 | 0 | 0 |
| TOTAL | $1,202 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,477 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 606 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | 0 | 0 | N/A | 0 |
| Retained earnings | -60,363 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 65,586 | 0 | 0 | 0 | 0 |
| TOTAL | $13,591 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $22,068 | $0 | $0 | $0 | $0 |